CHMP backs expanded approval of tocilizumabJuly 2, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Doc reports favorable results from trial on holdJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Group updates guidelines on CLLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
CPI-613 receives orphan designation for BLJune 29, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Many CCSs not concerned about future healthJune 28, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsRelated Issues
Ibrutinib sNDA receives priority reviewJune 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
T-cell therapy induced CMRs with no CRSJune 24, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Inhibitor exhibits activity in B- and T-cell NHLsJune 21, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Combo proves ‘beneficial’ for ‘unfit’ CLL patientsJune 20, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA places SB-generated CAR T-cell therapy on clinical holdJune 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Peripheral blood MRD correlates with treatment benefit in CLLJune 18, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
‘Excellent’ survival with HCT despite early treatment failure in FLJune 16, 2018Lymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Interim PET scans identify HL patients with better outcomesJune 16, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
FDA grants pembrolizumab accelerated approval for PMBCLJune 14, 2018Lymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
Ibrutinib and venetoclax combo promising in frontline CLLJune 13, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
